| Novo Nordisk Pharma AG - NovoSeven 8 mg, raumtemperaturstabiles Injektionspräparat | | 58693 | | 04 | | NovoSeven 8 mg | | raumtemperaturstabiles Injektionspräparat | | B02BD08 | | Coagulation Factor Viia | | 12.03.2012 | | |
| | Composition | | Praeparatio cryodesiccata: eptacogum alfa (activatum) 8 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 4 mg, pro vitro.
Solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 8.3 ml.
Solutio reconstituta: eptacogum alfa (activatum) 8 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 8 ml. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | Injection preparation, stable at room temperature | | | | | | Active Agent | Dose |
|---|
| Eptacog Alfa | 8 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Calcium Chloride | | | | Glycyl-Glycinum | | | | Mannitol | | | | Methionine | 4 mg | antiox. | | Sodium Chloride | | | | Polysorbatum 80 | | | | Saccharum | | |
|
| Solvens | | Injection preparation, stable at room temperature | | | | | | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 008 | Set(s) | PR | PR | B | | Yes |
|
|
